MOODY ALDRICH PARTNERS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOODY ALDRICH PARTNERS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$2,193,000
-13.1%
22,001
+0.1%
0.66%
+27.6%
Q4 2019$2,525,000
-8.1%
21,973
+0.9%
0.52%
-29.0%
Q3 2019$2,747,000
+4.0%
21,776
-0.8%
0.73%
+8.3%
Q2 2019$2,642,000
+0.9%
21,957
-26.6%
0.68%
-8.2%
Q1 2019$2,618,000
-11.2%
29,926
+1.5%
0.74%
-24.1%
Q4 2018$2,949,000
-6.1%
29,475
+7.5%
0.97%
+7.0%
Q3 2018$3,142,000
+51.9%
27,421
+18.9%
0.90%
+23.0%
Q2 2018$2,069,00023,0660.74%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders